Invest in ME Conference 12: First Class in Every Way
OverTheHills wraps up our series of articles on this year's 12th Invest in ME International Conference (IIMEC12) in London with some reflections on her experience as a patient attending the conference for the first time.
Discuss the article on the Forums.

Medscape: Rituximab biosimilars shown to be safe and effective

Discussion in 'General ME/CFS News' started by Kalliope, Aug 1, 2017.

  1. Kalliope

    Kalliope Senior Member

    Article from Medscape (July 28)

    Clinical trial data showing that two biosimilar rituximab products are comparable to the reference product, Rituxan (Genentech) (in Europe, MabThera), were published online July 13 in the Lancet Haematology.

    "The results of these two trials will certainly promote the introduction of rituximab biosimilar into daily, clinical practice in the immediate future," write editorialists in an accompanying commentary.


See more popular forum discussions.

Share This Page